Lv1
16 积分 2026-06-02 加入
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
52分钟前
已完结
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
2小时前
已完结
Targeting ADAR1 with a small molecule for the treatment of prostate cancer
2个月前
已完结
皖公网安备34019202002308
